Рыночные новости
Заголовки по акциям и крипте из Alpaca. Храним 7 дней. Всего: 9779.
-
Wedbush Adjusts BioCryst Pharmaceuticals Price Target to $17Wedbush maintained its Outperform rating on BioCryst Pharmaceuticals while adjusting its price target to $17 from $18.
-
BofA Securities Raises Price Target on Addus HomeCareBofA Securities increased its price target for Addus HomeCare Corporation to $131 from $125.
-
RBC Capital Markets Lowers Price Target on IDEAYA Biosciences to $45RBC Capital Markets adjusted its price target for IDEAYA Biosciences to $45 from $48 while maintaining an 'Outperform' rating.
-
ePlus Inc. Recognized as NetApp FY26 Partner Award WinnerePlus Inc. received multiple honors in the NetApp North America Partner Awards for fiscal year 2026, including recognition for new account acquisition and flash revenue growth.
-
Needham Maintains Buy Rating on Navitas Semiconductor, Lowers Price TargetNeedham maintained its Buy rating on Navitas Semiconductor while adjusting its price target to $15 from $21.
-
Fairfax India Completes Subscription of Additional Equity Interest in IIFL Capital Services LimitedFairfax India Holdings Corporation has finalized the acquisition of an additional 11.2% equity interest in IIFL Capital Services Limited for approximately $211 million.
-
Upstart Reports Q3 2026 Earnings and Revises Annual OutlookUpstart Holdings, Inc. reported third-quarter 2026 financial results, exceeding analyst estimates for revenue and earnings while lowering its full-year 2026 guidance due to macroeconomic headwinds.
-
Oppenheimer Raises Price Target on Tarsus Pharmaceuticals to $103Oppenheimer has increased its price target for Tarsus Pharmaceuticals from $100 to $103 while maintaining an Outperform rating.
-
Nomura Initiates Coverage of AXT, Inc. with Buy RatingNomura has initiated coverage on AXT, Inc. with a "Buy" rating and a price target of $90.
-
Needham Raises Price Target on AtriCure to $70 From $64, Keeps Buy RatingNeedham has maintained its 'Buy' rating on AtriCure, Inc. while increasing its price target for the company's shares from $64 to $70.
-
Joby Aviation Secures Additional U.S. Air Force Funding for Autonomous Flight TechnologyJoby Aviation announced that the U.S. Air Force has awarded additional funding to accelerate its autonomous flight technology, increasing the total commitment to nearly $37 million and raising the operational testing contract ceiling to $50 million.
-
Wedbush Cuts Price Target on Rigetti Computing to $25 From $37Wedbush Securities has lowered its price target for Rigetti Computing, Inc. while maintaining an Outperform rating on the stock.
-
Five9 Recognized with Top Industry Awards at Sandler Partners 2026 National SummitFive9 received the "Top Contact Center & CX Provider" and "Largest Revenue Growth" awards at the 2026 Sandler Partners National Summit.
-
Bernstein Reduces Price Target for MARA Holdings, Inc.Bernstein has lowered its price target for MARA Holdings, Inc. from $17 to $10, citing concerns over tighter financing markets and industry uncertainty in Texas.
-
UBS Adjusts Price Target on Cabot Corporation to $80 From $86UBS has lowered its price target for Cabot Corporation to $80 from $86 while maintaining a neutral rating on the stock.
-
Extreme Networks Deploys Wi-Fi 7 Infrastructure at BayArenaExtreme Networks has upgraded the BayArena stadium in Germany with over 400 Wi-Fi 7 access points to enhance connectivity and security for fans and operations.
-
UBS Adjusts RXO Price Target to $30.25 From $23, Maintains Neutral RatingUBS has updated its price target for RXO, Inc. to $30.25 while maintaining a neutral rating on the stock.
-
Caliber Launches Tokenized Investment Offerings for Hyatt Studios HotelsCaliber has launched three new tokenized real estate investment offerings, including two Hyatt Studios hotel developments.
-
Steel Dynamics Insider Executes Significant Stock SaleA corporate insider at Steel Dynamics, Inc. sold shares valued at approximately $12.45 million, as disclosed in a recent SEC filing.
-
RBC Capital Markets Raises Price Target on Eastman Chemical to $70RBC Capital Markets has increased its price target for Eastman Chemical Company from $65 to $70 while maintaining a Sector Perform rating.